Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent chemotherapy or anti‐CD20 therapy-Reference-Cited by-同舟云学术

Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent chemotherapy or anti‐CD20 therapy

Published:2021-11-10 Issue:4 Volume:196 Page:892-901
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Booth Stephen¹,Curley Helen M.²^ORCID,Varnai Csilla²³,Arnold Roland²,Lee Lennard Y. W.²⁴,Campton Naomi A.⁵,Cook Gordon⁶^ORCID,Purshouse Karin⁷,Aries James⁸,Innes Andrew⁹,Cook Lucy B.⁹,Tomkins Oliver¹⁰^ORCID,Oram Helen S.¹⁰,Tilby Michael¹¹,Kulasekararaj Austin¹²^ORCID,Wrench David¹³,Dolly Saoirse¹³,Newsom‐Davies Tom¹⁴,Pettengell Ruth¹⁵^ORCID,Gault Abigail¹⁶,Moody Sam¹⁶,Mittal Sajjan¹⁷,Altohami Mohammed¹⁷^ORCID,Tillet Tania¹⁸,Illingworth Jack¹⁹,Mukherjee Leena²⁰,Apperly Jane⁹,Ashcroft John⁶²¹,Rabin Neil²²,Carmichael Jonathan⁶^ORCID,Cazier Jean‐Baptiste²³,Kerr Rachel⁴,Middleton Gary²³,Collins Graham P.¹,Palles Claire²^ORCID,

Affiliation:

1. Oxford NIHR Biomedical Research Centre Department of Haematology Churchill Hospital OxfordUK

2. Institute of Cancer and Genomic Sciences University of Birmingham BirminghamUK

3. Centre for Computational Biology University of Birmingham BirminghamUK

4. Department of Oncology Oxford University OxfordUK

5. Institute of Translational Medicine Birmingham Health Partners BirminghamUK

6. NIHR (Leeds) MIC, Leeds St James's Teaching Hospital, University of Leeds LeedsUK

7. Edinburgh Cancer Research Centre University of Edinburgh EdinburghUK

8. Barts Health NHS Trust LondonUK

9. Imperial College Healthcare NHS Trust LondonUK

10. Leswisham and Greenwich NHS Trust LondonUK

11. Queen Elizabeth Hospital BirminghamUK

12. Department of Haematology King's College Hospital LondonUK

13. Guys and St Thomas' NHS Foundation Trust LondonUK

14. Chelsea and Westminster Hospital NHS Foundation Trust LondonUK

15. St Georges University Hospitals NHS Foundation Trust LondonUK

16. NCCC Northern Centre for Cancer Care The Newcastle Upon Tyne NHS Foundation Trust NewcastleUK

17. Northampton General Hospital NHS Trust NorthamptonUK

18. Royal United Hospitals Bath BathUK

19. Barking Havering and Redbridge University Hospitals NHS Trust EssexUK

20. Beatson West of Scotland Cancer Centre GlasgowUK

21. Mid Yorkshire Hospitals NHS Trust WakefieldUK

22. University College London Hospitals LondonUK

23. Institute of Immunology and Immunotherapy University of Birmingham Edgbaston Birmingham UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17937

Reference21 articles.

1. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study

2. Factors associated with COVID-19-related death using OpenSAFELY

3. VárnaiC PallesC ArnoldR CurleyHM PurshouseK ChengVWT et al.A prospective observational study investigating mortality among adults with cancer undergoing chemotherapy or immunotherapy infected with COVID‐19. (Submitted under review) 2021.

4. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

5. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Features of the T-cell immune response in patients with hematological diseases after SARS-CoV-2 infection and vaccination;Russian journal of hematology and transfusiology;2024-08-18

2. Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide;Blood Reviews;2024-07

4. Impact of SARS-CoV-2 infection on patients with hematological malignancies: a retrospective study;Hematology;2023-12-08

5. COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients;Scientific Reports;2023-12-01